Navigation Links
Bavarian Nordic Publishes its Annual Results 2008
Date:3/27/2009

ions in Actavis A/S.

Bavarian Nordic awards warrants

The Board of Directors in Bavarian Nordic A/S has today decided to award warrants to a member of executive management and employees in the Company and its subsidiaries. The Board decision is made in accordance with the shareholder authorisation for the Board of Directors adopted as Article 5f of the Articles of Association and the Company's guidelines regarding incentive programs. The award is made by the Board of Directors and exercise is limited by and governed by the Danish Act on Options for Employees (the Stock Option Act/aktieoptionsloven) regarding termination of employment prior to exercise of warrants.

A total of 25,000 warrants are awarded for subscription of up to 25,000 shares of a nominal value of DKK 10 at an exercise price of DKK 124 per share. The exercise price has been established on the basis of the average share price ("closing price") for the Company's share in a period of 15 business days prior to this day added a 15 % premium. However, the exercise price must at least be equal to the Company's average exchange-listed price today. In the event that the average exchange-listed price on the Company's shares today exceeds DKK 124 the exercise price shall be increased accordingly. If this becomes relevant the Company will make a separate announcement to NASDAQ OMX.

The warrants can be exercised wholly or partly in a period of 14 days commencing from the day of publication of the Company's Annual Report for 2011, from the day of publication of the Company's Half Yearly Interim Results for 2012, from the day of publication of the Company's Annual Report for 2012 and in a period of 14 days commencing from the day of publication of the Company's Half Yearly Interim Results for 2013.

Referring to the Danish Securities Act, Section 28a it is announced that Steen Vangsgaard, who is a member of executive manageme
'/>"/>

SOURCE Bavarian Nordic A/S
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Bavarian Nordic Receives $50 Million Advance Payment from HHS for Fulfilling Contract Milestones
2. Bavarian Nordic Update - 2007 Annual Results, IMVAMUNE(R) Delivery Contract, Strategy Process
3. Bavarian Nordic A/S - Interim Report for the Period 1 January to 30 June 2008
4. Bavarian Nordic Receives USD 25 Million Milestone Payment After Submission of Important IMVAMUNE(R) Data to The U.S. Health Authorities
5. Bavarian Nordics Case Against Oxford BioMedica
6. Bavarian Nordic Has Essentially Agreed a Pathway for the Licensure of IMVAMUNE(R) With the FDA After Successful End of Phase II Meeting
7. Circulation Publishes MERLIN TIMI-36 Data Showing Safety and Anti-Arrhythmic Effects of Ranexa(R)
8. Thomson Scientific Publishes Who Is Making The Biggest Splash? - A Quarterly Review of Scientific Literature on Drugs and Therapies From April - June 2007
9. Consortium publishes Phase II map of human genetic variation
10. The Lancet Publishes Vasogens ACCLAIM Results
11. Dendreon Publishes Manuscript on CD54 as a Surrogate Marker of Antigen Presenting Cell Activation

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...,Nov.24/PRNewswire-FirstCall/--Sigma-AldrichCorpor...conferenceonTuesday,December1stat1:45PMGMTinLondon...iobroadcastovertheInternetavailableat http://inve...the"Webcast"icontoaccessthisfile. ,, AboutSig...HighTechnologycompany.Itschemicalandbiochemicalpro...
(Date:11/24/2009)...,Nov.24/PRNewswire-Asia/--ShanghaiBiolaxyannounced...asapprovedthe,investigationalnewdrugapplication(IN...sulinformulationtotreatdiabetes.ThisIND,approvalal..., Diabetesisadisordercharacteristicofhighbloo...tesoftenresultinseveremicro-and,macro-vasculardise...
(Date:11/24/2009)...ovember24/PRNewswire-FirstCall/--Shireplc(LSE:SHP,...alcompany,today,announcedthatithassubmittedaMAAtot...company,senzymereplacementtherapyindevelopment,for...rketing,applicationforvelaglucerasealfathathasbeen...sandCanada. , Basedonaglobalsupplyshortageoft...
(Date:11/24/2009)... Chemical Abstracts Service (CAS), the gl...China,s patent office is now the world,s leading p...try. China trailed Japan,s patent office, the Worl...he United States Patent and Trademark Office (USPT... 2005, WIPO in 2006, and exceeded Japan for the fi...
Breaking Biology Technology:Biolaxy Secures IND Approval for Oral Insulin 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 3
...HIA, Pennsylvania, April 15, THIS ANNOUNCEMENT IS ...S SHOULD NOT SUBSCRIBE FOR OR PURCHASE ANY,SECURIT... BASIS OF,INFORMATION TO BE CONTAINED IN THE PROSP... CONNECTION WITH THE PROPOSED SCHEME. THE PROSPECT... WEBSITE AND WILL BE AVAILABLE,FOR INSPECTION AT T...
...ives reimbursement approval; Company ...Mass., April 14 Boston Scientific,Corporation (NY...alth, Labor,and Welfare (MHLW) approval of its ACU...h cardiac resynchronization therapy (CRT) devices,...ved reimbursement approval for,the lead from the N...
...ts at American Society of Pharmacognosy, EMERYVIL... ) will present seminal information on a new drug ...the 7th Annual Oxford International,Conference on ...armacognosy,4th Interim Meeting, April 12-16, 2008...istry team, will present the structural elucidatio...
Other Biology Technology:Shire to Introduce a New UK Listed Holding Company 2Shire to Introduce a New UK Listed Holding Company 3Shire to Introduce a New UK Listed Holding Company 4Shire to Introduce a New UK Listed Holding Company 5Shire to Introduce a New UK Listed Holding Company 6Shire to Introduce a New UK Listed Holding Company 7Boston Scientific Announces Japanese Approval of Heart Failure Lead 2Boston Scientific Announces Japanese Approval of Heart Failure Lead 3Bionovo Identifies and Describes ER-beta Selective Compounds for the Treatment of Vaginal Dryness 2Bionovo Identifies and Describes ER-beta Selective Compounds for the Treatment of Vaginal Dryness 3
(Date:11/26/2009)...eer have been caught in the hunters, sights for ge... decorative. They are lethal weapons that stags cr...University of York, UK, has been intrigued by the ...ury and has become fascinated by the mechanical pr...ration with Tomas Landete-Castillejos at the Unive...
(Date:11/26/2009)...ehead researchers have developed a new type of gen...enes and proteins used by pathogens, according to ...ultures genes are present in two copies: one inher... inactivation by mutation is therefore inefficient...copy usually remains active and takes over. , In...
(Date:11/25/2009)...ia Institute of Technology (Caltech) have uncovere... the fruit fly, Drosophila melanogaster . , The...ship between the neurotransmitter dopamine and att...described in the December issue of the journal Ne...out 20,000 neurons and has long been considered a ...
Breaking Biology News(10 mins):Tough yet stiff deer antler is materials scientist's dream 2Knockouts in human cells point to pathogenic targets 2Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 2Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 3Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 4Quest Diagnostics HemoCue Subsidiary to Add U S Hospital Laboratory Connectivity to Its HemoCue 201 DM Point of Care Systems 49601 1Quest Diagnostics HemoCue Subsidiary to Add U S Hospital Laboratory Connectivity to Its HemoCue 201 DM Point of Care Systems 49601 2Quest Diagnostics HemoCue Subsidiary to Add U S Hospital Laboratory Connectivity to Its HemoCue 201 DM Point of Care Systems 49601 3 New Strategy Eyed for AIDS Treatment 49598 1 New Strategy Eyed for AIDS Treatment 49598 2Sechrist Industries Introduces Ground Check System to Verify NFPA Ground Requirements in Hyperbaric Chambers 49593 1Sechrist Industries Introduces Ground Check System to Verify NFPA Ground Requirements in Hyperbaric Chambers 49593 2
...be nutritious and tasty, but don’t count on them t...ncer Epidemiology, Biomarkers & Prevention, re...nd Fred Hutchinson Cancer Research Center report t...n tomatoes, does not effectively prevent prostate ...tion between beta-carotene, an antioxidant related...
...lyzing whale meat sold in Korean markets suggests ...ion in the Asian country is much higher than that ...sion ?putting threatened populations of coastal mi... numerous researchers led by Scott Baker of Oregon...al Molecular Ecology. Baker, who is associate dire...
...he Universitat Autònoma de Barcelona (UAB), in coo...ro-chemical biosensor which detects the presence, ... the most widely used herbicides in agriculture an...environment- as well as antibiotics in food. The b...n the expensive laboratory methods which are used ...
Other Biology News:No magic tomato? Study breaks link between lycopene and prostate cancer prevention 2DNA analysis suggests under-reported kills of threatened whales 2DNA analysis suggests under-reported kills of threatened whales 3A new portable biosensor detects traces of contaminants in food more quickly and cheaply 2
Rabbit Anti-Pendrin (H-195) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Thermal paper, high gloss, 5 rolls (1000 images) from UVP
Analog thermal printer, Mitsubishi (115V) for all UVP imaging systems except BioDoc-It and VisiDoc-It from UVP
384 Round Well Plate Sterile with lid from Thermo Scientific
Biology Products: